Scott N. Boyle
Chief Business Officer · C4 Therapeutics, Inc.
Individual
- 2024
- Feb 18, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Scott N. Boyle files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Leonard Reyno - $22K in CCCC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Scott N. Boyle?
Scott N. Boyle is a corporate insider, tracked as Chief Business Officer of C4 Therapeutics, Inc. (CCCC). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Scott N. Boyle last file a Form 4?
The most recent primary Form 4 on record is dated 18 February 2026, one of 2 filings going back to 2024.
